Advanced search

  • Polish Heart Journal (Kardiologia Polska)
  • Online first Expert opinion of the Heart Failure Association of the Polish Cardiac Society and the Polish Psychiatric Association on the management of patients with heart failure and selected mental disorders (depression, anxiety disorders, sleep disorders, delirium)
Online first
Expert opinion
Published online: 2024-10-23

open access

View PDF Download PDF file
Page views 210
Article views/downloads 143
Get Citation

Connect on Social Media

Connect on Social Media

Expert opinion of the Heart Failure Association of the Polish Cardiac Society and the Polish Psychiatric Association on the management of patients with heart failure and selected mental disorders (depression, anxiety disorders, sleep disorders, delirium)

Agnieszka Pawlak1, Agata Bielecka-Dąbrowa23, Tomasz Dzierżanowski4, Paweł Holas5, Izabela Jaworska6, Jolanta Kolasa7, Anna Tomaszuk-Kazberuk8, Anna Mierzyńska9, Andrzej Muszala10, Robert Pudlo11, Joanna Rymaszewska12, Piotr Sobański1314, Dominika Dudek15
DOI: 10.33963/v.phj.103100
Pubmed: 39440753

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Savarese G, Becher P, Lund L, et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovascular Res. 2022; 118(17): 3272–3287.
    CrossRefPubMed
  2. Mauro C, Chianese S, Cocchia R, et al. Acute heart failure: diagnostic-therapeutic pathways and preventive strategies-a real-world clinician's guide. J Clin Med. 2023; 12(3): 846.
    CrossRefPubMed
  3. Celano C, Villegas A, Albanese A, et al. Depression and anxiety in heart failure: a review. Harv Rev Psychiatry. 2018; 26(4): 175–184.
    CrossRefPubMed
  4. Asocjacja Niewydolności Serca PTK. Niewydolność serca w Polsce 2014–2021. https://www.niewydolnosc-serca.pl/doc/ANS_raport_01.09_.pdf (August 1, 2024).
  5. Moradi M, Doostkami M, Behnamfar N, et al. Global prevalence of depression among heart failure patients: a systematic review and meta-analysis. Curr Probl Cardiol. 2022; 47(6): 100848.
    CrossRefPubMed
  6. Daskalopoulou M, George J, Walters K, et al. Depression as a risk factor for the initial presentation of twelve cardiac, cerebrovascular, and peripheral arterial diseases: data linkage study of 1.9 million women and men. PLoS One. 2016; 11(4): e0153838.
    CrossRefPubMed
  7. Easton K, Coventry P, Lovell K, et al. Prevalence and measurement of anxiety in samples of patients with heart failure. Journal of Cardiovascular Nursing. 2016; 31(4): 367–379.
    CrossRefPubMed
  8. Sokoreli I, de Vries JJG, Pauws SC, et al. Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis. Heart Fail Rev. 2016; 21(1): 49–63.
    CrossRefPubMed
  9. Broström A, Strömberg A, Dahlström U, et al. Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs. 2004; 19(4): 234–242.
    CrossRefPubMed
  10. Redeker N, Jeon S, Muench U, et al. Insomnia symptoms and daytime function in stable heart failure. Sleep. 2010; 33(9): 1210–1216.
    CrossRefPubMed
  11. Laugsand LE, Strand LB, Platou C, et al. Insomnia and the risk of incident heart failure: a population study. Eur Heart J. 2014; 35(21): 1382–1393.
    CrossRefPubMed
  12. Honda S, Nagai T, Sugano Y, et al. Prevalence, determinants, and prognostic significance of delirium in patients with acute heart failure. Int J Cardiol. 2016; 222: 521–527.
    CrossRefPubMed
  13. Pak M, Hara M, Miura S, et al. Delirium is associated with high mortality in older adult patients with acute decompensated heart failure. BMC Geriatr. 2020; 20(1): 524.
    CrossRefPubMed
  14. Shen Q, Mikkelsen D, Luitva L, et al. Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countries. eClinicalMedicine. 2023; 61: 102063.
    CrossRefPubMed
  15. Aimo A, Castiglione V, Borrelli C, et al. Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies. Eur J Prev Cardiol. 2020; 27(5): 494–510.
    CrossRefPubMed
  16. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011; 301(6): H2181–H2190.
    CrossRefPubMed
  17. Shao M, Lin X, Jiang D, et al. Depression and cardiovascular disease: shared molecular mechanisms and clinical implications. Psychiatry Res. 2020 [Epub ahead of print]; 285: 112802.
    CrossRefPubMed
  18. Wu WC, Luh DL, Lin CI, et al. Reciprocal relationship between unhealthy eating behaviours and depressive symptoms from childhood to adolescence: 10-year follow-up of the Child and Adolescent Behaviors in Long-Term Evolution study. Public Health Nutr. 2016; 19(9): 1654–1665.
    CrossRefPubMed
  19. Osborne M, Shin L, Mehta N, et al. Disentangling the links between psychosocial stress and cardiovascular disease. Circ Cardiovasc Imaging. 2020; 13(8): e010931.
    CrossRefPubMed
  20. Kivimäki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol. 2018; 15(4): 215–229.
    CrossRefPubMed
  21. Marano G, Traversi G, Romagnoli E, et al. Cardiologic side effects of psychotropic drugs. J Geriatr Cardiol. 2012; 8(4): 243–253.
    CrossRefPubMed
  22. Beach SR, Celano CM, Sugrue AM, et al. QT prolongation, torsades de pointes, and psychotropic medications: a 5-year update. Psychosomatics. 2018; 59(2): 105–122.
    CrossRefPubMed
  23. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016; 16(1): 22–34.
    CrossRefPubMed
  24. Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008; 5(4): e78.
    CrossRefPubMed
  25. Carney RM, Rich MW, Tevelde A, et al. Major depressive disorder in coronary artery disease. Am J Cardiol. 1987; 60(16): 1273–1275.
    CrossRefPubMed
  26. Hallas CN, Wray Jo, Andreou P, et al. Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart Lung. 2011; 40(2): 111–121.
    CrossRefPubMed
  27. Moser DK. "The rust of life": impact of anxiety on cardiac patients. Am J Crit Care. 2007; 16(4): 361–369.
    PubMed
  28. McDonagh T, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
    CrossRefPubMed
  29. National Institute for Health and Care Excellence (NICE). Depression in adults with a chronic physical health problem: recognition and management. Published: 28 October 2009. : October.
  30. Samochowiec J, Dudek D, Kucharska-Mazur J, et al. Diagnostyka i leczenie depresji u dorosłych – wytyczne dla lekarzy rodzinnych, Polskie Towarzystwo Psychiatryczne i Naczelna Izba Lekarska 2019.
  31. Dominiak M, Antosik-Wójcińska AZ, Baron M, et al. Rekomendacje odnośnie profilaktyki i leczenia depresji w Podstawowej Opiece Zdrowotnej (POZ) wraz z propozycją programu profilaktyczno-edukacyjnego zapobiegania depresji. Instytut Psychiatrii i Neurologii. Warszawa 2018.
  32. Beck AT, Steer RA, Brown GK. BDI®-II Inwentarz Depresji Becka – Wydanie drugie. Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego, Warszawa 2019.
  33. Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003; 1: 29.
    CrossRefPubMed
  34. Karakuła H, Grzywa A, Spila B, et al. Use of Hospital Anxiety and Depression Scale in psychosomatic disorders [article in Polish]. Psychiatr Pol. 1996; 30(4): 653–667.
    PubMed
  35. https://www.phqscreeners (August 1, 2024).
  36. Kokoszka A, Jastrzębski A, Obrębski M, et al. Ocena psychometrycznych właściwości polskiej wersji Kwestionariusza Zdrowia Pacjenta-9 dla osób dorosłych. Psychiatry. 2016; 13(4): 187–193.
  37. Nezlek J, Rusanowska M, Holas P, et al. The factor structure of a Polish language version of the hospital anxiety depression scale (HADS). Current Psychology. 2019; 40(5): 2318–2326.
    CrossRef
  38. Löwe B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008; 46(3): 266–274.
    CrossRefPubMed
  39. Laugsand LE, Strand LB, Platou C, et al. Insomnia and the risk of incident heart failure: a population study. Eur Heart J. 2013; 35(21): 1382–1393.
    CrossRefPubMed
  40. Parati G, Lombardi C, Castagna F, et al. Italian Society of Cardiology (SIC) Working Group on Heart Failure members. Heart failure and sleep disorders. Nat Rev Cardiol. 2016; 13(7): 389–403.
    CrossRefPubMed
  41. Ali RM, Zolezzi M, Awaisu A. A systematic review of instruments for the assessment of insomnia in adults. Nat Sci Sleep. 2020; 12: 377–409.
    CrossRefPubMed
  42. Fornal-Pawlowska M, Wolynczyk-Gmaj D, Szelenberger W. Walidacja Ateńskiej Skali Bezsenności [article in Polish]. Psychiatr Pol. 2011; 45(2): 211–219.
  43. Morin CM, Belleville G, Bélanger L, et al. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011; 34(5): 601–608.
    CrossRefPubMed
  44. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990; 113(12): 941–948.
    CrossRefPubMed
  45. Schuurmans MJ, Shortridge-Baggett LM, Duursma SA. The delirium observation screening scale: a screening instrument for delirium. Res Theory Nurs Pract. 2003; 17(1): 31–50.
    CrossRefPubMed
  46. Kodeks Etyki Lekarskiej. https://nil.org.pl/dokumenty/kodeks-etyki-lekarskiej (December 3, 2023).
  47. Rajeswaran T, Plymen CM, Doherty AM. The effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression - a systematic review. Int J Psychiatry Clin Pract. 2018; 22(3): 164–169.
    CrossRefPubMed
  48. Swenson JR, Doucette S, Fergusson D. Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials. Can J Psychiatry. 2006; 51(14): 923–929.
    CrossRefPubMed
  49. Shapiro PA, Lespérance F, Frasure-Smith N, et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. Am Heart J. 1999; 137(6): 1100–1106.
    CrossRefPubMed
  50. O'Connor C, Jiang W, Kuchibhatla M, et al. Safety and efficacy of sertraline for depression in patients with heart failure. J Am Coll Cardiol. 2010; 56(9): 692–699.
    CrossRefPubMed
  51. Hedrick R, Korouri S, Tadros E, et al. The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: a systematic review. Drugs Context. 2020; 9.
    CrossRefPubMed
  52. Marashdeh RAM, Parsons R, Sim TF. Antidepressant prescribing patterns in heart failure patients at residential aged care facilities in Australia: A cross-sectional study. J Res Pharm Pract. 2019; 8(2): 69–74.
    CrossRefPubMed
  53. Teply RM, Packard KA, White ND, et al. Treatment of depression in patients with concomitant cardiac disease. Prog Cardiovasc Dis. 2016; 58(5): 514–528.
    CrossRefPubMed
  54. Dudek D. Depresja. In: Jarema M. ed. Standardy leczenia farmakologicznego niektórych zaburzeń psychicznych. Via Medica, Gdańsk 2022: 55–92.
  55. Podolecki T, Pudlo R, Mazurek M, et al. The incidence, clinical significance, and treatment effects of depression in cardiac resynchronization therapy recipients. Cardiology. 2017; 138(2): 115–121.
    CrossRefPubMed
  56. Xue F, Strombom I, Turnbull B, et al. Treatment with duloxetine in adults and the incidence of cardiovascular events. J Clin Psychopharmacol. 2012; 32(1): 23–30.
    CrossRefPubMed
  57. Zivin K, Pfeiffer P, Bohnert A, et al. Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry. 2013; 170(6): 642–650.
    CrossRefPubMed
  58. Jiang W, Krishnan R, Kuchibhatla M, et al. SADHART-CHF Investigators. Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Am J Cardiol. 2011; 107(4): 545–551.
    CrossRefPubMed
  59. Chernoff RA, Messineo G, Kim S, et al. Psychosocial interventions for patients with heart failure and their impact on depression, anxiety, quality of life, morbidity, and mortality: a systematic review and meta-analysis. Psychosom Med. 2022; 84(5): 560–580.
    CrossRefPubMed
  60. Nahlén Bose C. A meta-review of systematic reviews and meta-analyses on outcomes of psychosocial interventions in heart failure. Front Psychiatry. 2023; 14: 1095665.
    CrossRefPubMed
  61. Cassidy L, Hill L, Fitzsimons D, et al. The impact of psychoeducational interventions on the outcomes of caregivers of patients with heart failure: A systematic review and meta-analysis. Int J Nurs Stud. 2021; 114: 103806.
    CrossRefPubMed
  62. de Oliveira FW, Nunes BP, Lobato FL, et al. Psychoeducational intervention for reducing heart failure patients' rehospitalizations and promoting their quality of life and posttraumatic growth at the 1-year follow-up: a randomized clinical trial. Psychosom Med. 2023; 85(3): 273–279.
    CrossRefPubMed
  63. Sullivan M, Wood L, Terry J, et al. The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): A mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J. 2009; 157(1): 84–90.
    CrossRefPubMed
  64. Gathright EC, Salmoirago-Blotcher E, DeCosta J, et al. Stress management interventions for adults with heart failure: Systematic review and meta-analysis. Health Psychol. 2021; 40(9): 606–616.
    CrossRefPubMed
  65. Helal SI, Lee G, Evans C, et al. The efficacy of psychological interventions on health-related quality of life for patients with heart failure and depression: a systematic review. J Cardiovasc Nurs. 2022; 37(2): 134–145.
    CrossRefPubMed
  66. Viveiros J, Chamberlain B, O'Hare A, et al. Meditation interventions among heart failure patients: an integrative review. Eur J Cardiovasc Nurs. 2019; 18(8): 720–728.
    CrossRefPubMed
  67. Ishak WW, Edwards G, Herrera N, et al. Depression in heart failure: a systematic review. Innov Clin Neurosci. 2020; 17(4-6): 27–38.
    PubMed
  68. Freedland K, Carney R, Rich M, et al. Cognitive behavior therapy for depression and self-care in heart failure patients. JAMA Intern Med. 2015; 175(11): 1773–1782.
    CrossRefPubMed
  69. Rashid S, Qureshi A, Noor T, et al. Anxiety and depression in heart failure: an updated review. Curr Probl Cardiol. 2023; 48(11): 101987.
    CrossRefPubMed
  70. Scott-Sheldon L, Gathright E, Donahue M, et al. Mindfulness-Based interventions for adults with cardiovascular disease: a systematic review and meta-analysis. Ann Behav Med. 2019; 54(1): 67–73.
    CrossRefPubMed
  71. Zou H, Cao Xi, Geng J, et al. Effects of mindfulness-based interventions on health-related outcomes for patients with heart failure: a systematic review. Eur J Cardiovasc Nurs. 2020; 19(1): 44–54.
    CrossRefPubMed
  72. Redeker NS, Yaggi HK, Jacoby D, et al. Cognitive behavioral therapy for insomnia has sustained effects on insomnia, fatigue, and function among people with chronic heart failure and insomnia: the HeartSleep Study. Sleep. 2022; 45(1).
    CrossRefPubMed
  73. Harris KM, Schiele SE, Emery CF. Pilot randomized trial of brief behavioral treatment for insomnia in patients with heart failure. Heart Lung. 2019; 48(5): 373–380.
    CrossRefPubMed
  74. Stewart JG, McNulty R, Griffin MT, et al. Psychological empowerment and structural empowerment among nurse practitioners. J Am Acad Nurse Pract. 2010; 22(1): 27–34.
    CrossRefPubMed
  75. Cowie MR, Anker SD, Cleland JGF, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail. 2014; 1(2): 110–145.
    CrossRefPubMed
  76. Stamp K, Dunbar S, Clark P, et al. Family partner intervention influences self-care confidence and treatment self-regulation in patients with heart failure. Eur J Cardiovasc Nurs. 2015; 15(5): 317–327.
    CrossRefPubMed
  77. Baum E, Nowak A, Nowosadko M, Głodowska KB. Duchowe uwarunkowania opieki nad pacjentem. Termedia Wydawnictwa Medyczne, Poznań 2022: 63–69.
  78. https://ptodm.org (August 1, 2024).
  79. Frankl V. Człowiek w poszukiwaniu sensu. Czarna Owca, Warszawa 2016.
  80. Sobanski PZ, Alt-Epping B, Currow DC, et al. Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement. Cardiovasc Res. 2020; 116(1): 12–27.
    CrossRefPubMed
  81. Hill L, Prager Geller T, Baruah R, et al. Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper. Eur J Heart Fail. 2020; 22(12): 2327–2339.
    CrossRefPubMed
  82. Sobański PZ, Brzezińska Rajszys G, Grodzicki T, et al. Palliative care for people living with cardiac disease. Kardiol Pol. 2020; 78(4): 364–373.
    CrossRefPubMed
  83. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18): e895–e1032.
    CrossRefPubMed
  84. Szczeklik W, Krajnik M, Pawlikowski J. Zapobieganie terapii daremnej u dorosłych chorych umierających w szpitalu – stanowisko Grupy Roboczej Towarzystwa Internistów Polskich ds. Terapii Daremnej na Oddziałach Internistycznych. Med Prakt 2023: 121–140.

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note